The Board Meeting to be held on 25/07/2026 has been revised to 27/07/2026 Postponement of the Board Meeting to be held on Saturday, 25th July, 2026 and rescheduling of the board meeting ....

VIRUPAKSHA To, Date: 24.07.2026 The Manager BSE Limited P. J. Towers, Dalal Street Mumbai-400001 Dear Sir/ Madam, Unit: Oxygenta Pharmaceutical Ltd (Scrip: 524636) Sub: Postponement of the Board Meeting to be held on Saturday, 25% July, 2026 and rescheduling of the board meeting to 27% July, 2026. With reference to the cited subject, the Board Meeting scheduled to be held on Saturday, 25® day of July, 2026 at the corporate office of the company to consider and approve the business(s) i.e. unaudited financial results for the quarter ended 30™ June, 2026; Limited Review Report for the quarter ended 30™ June, 2026 and any other business with the permission of the Chair have been postponed to Monday, 27% day ofJ uly, 2026 at the corporate office of the company. This is for the information and records of the Exchange, please. Thanking you. Yours sincerely, For Oxygenta Pharmaceutical Ltd Kumkum Bajaj Company Secretary & Compliance Officer M No.: A76548 OXYGENTA PHARMACEUTICAL LIMITED (Subsidiary of VIRUPAKSHA ORGANICS LIMITED) (An 1SO 9001:2015, ISO 14001:2018 and ISO 45001:2015 Certified Company) Regd off.& Factory: Sy.No. 252/1, Aroor (V), Sadasivapet (M), Sangareddy (Dist)-502 291, Telangana, INDIA. Tel: 08455-250080 Corp. Office: Level-1, Plot No. B1 & B2, IDA Gandhi Nagar, Kukatpally, Hyderabad — 500 037, Telangana, INDIA. E-Mail id: info@oxygentapharma.com. Website: www.oxygentapharma.com, Phone 040-23073417, CIN: L24110TG1990PLC012038